NASDAQ:APDN

Applied DNA Sciences Stock Forecast, Price & News

$6.68
+0.09 (+1.37 %)
(As of 06/11/2021 12:00 AM ET)
Add
Compare
Today's Range
$6.42
$6.68
50-Day Range
$5.75
$8.23
52-Week Range
$4.95
$14.84
Volume84,794 shs
Average Volume1.11 million shs
Market Capitalization$50.01 million
P/E RatioN/A
Dividend YieldN/A
Beta1
30 days | 90 days | 365 days | Advanced Chart
Receive APDN News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter.


Applied DNA Sciences logo

About Applied DNA Sciences

Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes applications in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications and can be used to fortify brand protection efforts, and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide definitive real-time authentication of molecular tags in the field; and CertainT Supply Chain Platform that provides proof of product claims for materials, items, or products. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and non-diagnostic COVID-19 pooled surveillance testing to detect instances of COVID-19 in defined populations under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.37 out of 5 stars

Industrial Products Sector

156th out of 406 stocks

Miscellaneous Business Services Industry

3rd out of 17 stocks

Analyst Opinion: 3.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Applied DNA Sciences (NASDAQ:APDN) Frequently Asked Questions

Is Applied DNA Sciences a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Applied DNA Sciences in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Applied DNA Sciences stock.
View analyst ratings for Applied DNA Sciences
or view top-rated stocks.

What stocks does MarketBeat like better than Applied DNA Sciences?

Wall Street analysts have given Applied DNA Sciences a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Applied DNA Sciences wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Applied DNA Sciences?

Applied DNA Sciences saw a drop in short interest during the month of May. As of May 28th, there was short interest totaling 385,800 shares, a drop of 22.6% from the May 13th total of 498,200 shares. Based on an average trading volume of 591,900 shares, the short-interest ratio is presently 0.7 days. Currently, 5.7% of the company's stock are short sold.
View Applied DNA Sciences' Short Interest
.

When is Applied DNA Sciences' next earnings date?

Applied DNA Sciences is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for Applied DNA Sciences
.

How were Applied DNA Sciences' earnings last quarter?

Applied DNA Sciences, Inc. (NASDAQ:APDN) posted its earnings results on Wednesday, May, 12th. The technology company reported ($0.33) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.21) by $0.12. The technology company earned $2.67 million during the quarter, compared to analysts' expectations of $2.62 million. Applied DNA Sciences had a negative net margin of 272.49% and a negative trailing twelve-month return on equity of 135.50%.
View Applied DNA Sciences' earnings history
.

How has Applied DNA Sciences' stock price been impacted by COVID-19?

Applied DNA Sciences' stock was trading at $4.10 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, APDN shares have increased by 62.9% and is now trading at $6.68.
View which stocks have been most impacted by COVID-19
.

What guidance has Applied DNA Sciences issued on next quarter's earnings?

Applied DNA Sciences issued an update on its second quarter 2021 earnings guidance on Tuesday, May, 4th. The company provided earnings per share (EPS) guidance of - for the period. The company issued revenue guidance of $2.50 million-$2.70 million, compared to the consensus revenue estimate of $2.41 million.

What price target have analysts set for APDN?

3 analysts have issued 1-year target prices for Applied DNA Sciences' shares. Their forecasts range from $13.00 to $24.00. On average, they expect Applied DNA Sciences' share price to reach $18.33 in the next year. This suggests a possible upside of 174.5% from the stock's current price.
View analysts' price targets for Applied DNA Sciences
or view top-rated stocks among Wall Street analysts.

Who are Applied DNA Sciences' key executives?

Applied DNA Sciences' management team includes the following people:
  • Dr. James A. Hayward Ph.D., Sc.D., Chairman, Pres & CEO (Age 67, Pay $391.62k)
  • Ms. Beth M. Jantzen CPA, CPA, Chief Financial Officer (Age 45, Pay $278.27k)
  • Ms. Judith Murrah, COO & Sec. (Age 63, Pay $278.27k)
  • Mr. Scott L. Anchin, Strategic Advisor & Director (Age 47, Pay $325k)
  • Mr. Sanjay M. Hurry, Exec. Director of Investor Relations & Corp. Communications
  • Mr. Clay Shorrock Esq., J.D., Chief Legal Officer & Exec. Director of Bus. Devel.
  • Mr. John Shearman, Exec. Director of Marketing & Cannabis Bus.
  • Mr. Tony Benson, Managing Director of EMEA
  • Ms. Janice Meraglia, VP, Gov. & Military Programs
  • Ms. MeiLin Wan, VP of Textile Sales

What is James A. Hayward's approval rating as Applied DNA Sciences' CEO?

2 employees have rated Applied DNA Sciences CEO James A. Hayward on Glassdoor.com. James A. Hayward has an approval rating of 100% among Applied DNA Sciences' employees. This puts James A. Hayward in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Applied DNA Sciences' key competitors?

What other stocks do shareholders of Applied DNA Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Applied DNA Sciences investors own include Inovio Pharmaceuticals (INO), Advanced Micro Devices (AMD), Ekso Bionics (EKSO), Micron Technology (MU), Arbutus Biopharma (ABUS), VBI Vaccines (VBIV), Gilead Sciences (GILD), Vaxart (VXRT), Sorrento Therapeutics (SRNE) and Intel (INTC).

What is Applied DNA Sciences' stock symbol?

Applied DNA Sciences trades on the NASDAQ under the ticker symbol "APDN."

Who are Applied DNA Sciences' major shareholders?

Applied DNA Sciences' stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (1.20%), Schonfeld Strategic Advisors LLC (1.00%), Virtu Financial LLC (0.36%) and Premier Asset Management LLC (0.27%).
View institutional ownership trends for Applied DNA Sciences
.

Which major investors are buying Applied DNA Sciences stock?

APDN stock was bought by a variety of institutional investors in the last quarter, including Schonfeld Strategic Advisors LLC, Virtu Financial LLC, Premier Asset Management LLC, and BlackRock Inc..
View insider buying and selling activity for Applied DNA Sciences
or or view top insider-buying stocks.

How do I buy shares of Applied DNA Sciences?

Shares of APDN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Applied DNA Sciences' stock price today?

One share of APDN stock can currently be purchased for approximately $6.68.

How much money does Applied DNA Sciences make?

Applied DNA Sciences has a market capitalization of $50.01 million and generates $1.93 million in revenue each year. The technology company earns $-13,030,000.00 in net income (profit) each year or ($3.32) on an earnings per share basis.

How many employees does Applied DNA Sciences have?

Applied DNA Sciences employs 59 workers across the globe.

What is Applied DNA Sciences' official website?

The official website for Applied DNA Sciences is www.adnas.com.

Where are Applied DNA Sciences' headquarters?

Applied DNA Sciences is headquartered at 50 HEALTH SCIENCES DRIVE, STONY BROOK NY, 11790.

How can I contact Applied DNA Sciences?

Applied DNA Sciences' mailing address is 50 HEALTH SCIENCES DRIVE, STONY BROOK NY, 11790. The technology company can be reached via phone at 631-840-8800 or via email at [email protected]


This page was last updated on 6/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.